NeuroLoop: Building a Closed-Loop Brain System From EEG to Precision Intervention

What started as a question about reading the brain became a question about responding to it.

I did not start NeuroLoop with the idea of building something flashy. I started with a simpler, harder question: what if a brain interface could do more than observe? What if it could detect a dangerous state in real time and respond before that state escalates?

That question pulled me into the world of EEG, real-time signal processing, and closed-loop neurotechnology. NeuroLoop began as a software-first system built around that idea: take multichannel EEG, process it live, predict brain-state transitions, and trigger an intervention loop. The first version runs as a simulation, but the architecture is intentionally designed to connect to real-time hardware later.

The reason this matters is that modern neurotechnology is already moving in that direction. g.tec, for example, provides platforms for real-time EEG/ECoG acquisition and processing, with software tooling that includes Python, MATLAB, and LSL interfaces for building custom applications and closed-loop experiments. Their suite is explicitly designed for rapid prototyping, real-time analysis, and integration with biosignal hardware. (g.tec medical engineering)

At its core, NeuroLoop is a pipeline. EEG comes in. Signal processing cleans it. A model estimates whether the brain is moving toward a dangerous state. A decision layer checks confidence and timing. Then the system triggers an intervention, and the loop continues. That sounds simple on paper, but what makes it interesting is latency, reliability, and the possibility of closing the loop fast enough to matter in the real world.

That is where I started looking beyond standard stimulation.

For decades, electrical stimulation has been the default way to influence brain activity. It is effective, but broad. It can affect a whole region rather than a specific cell type or circuit. Optogenetics changes that. It uses light-sensitive proteins called opsins, such as Channelrhodopsin, halorhodopsin, and Arch, to control neural activity with much higher spatial and cell-type specificity. In other words, it is not just “stimulate the brain.” It is “target the right neurons in the right circuit at the right time.” (PMC)

Once I understood that, the design space became much bigger. Optogenetics is not a replacement for EEG or BCI systems. It is a precision actuation layer that could sit behind them. A system like NeuroLoop can do the sensing and prediction. A stimulation layer can then do the response. The exciting part is that research has already shown this logic works.

A landmark closed-loop study in mice demonstrated that optogenetic intervention could stop spontaneous seizures in real time. The authors showed that either optogenetic inhibition of excitatory principal cells or activation of a small GABAergic population was enough to rapidly suppress seizures. That is an important proof point because it shows that closed-loop detection plus targeted intervention is not just a theoretical idea. It is a working biological strategy. (Nature)

There is also clinical precedent. In 2021, a Nature Medicine report described partial recovery of visual function in a blind patient after optogenetic therapy, which marked the first reported case of partial functional recovery in a neurodegenerative disease after optogenetic treatment. That does not mean optogenetics is ready to be dropped into every clinical workflow tomorrow, but it does mean the field is no longer purely conceptual. (Nature)

What I find most compelling about NeuroLoop is not just the technical stack. It is the direction of travel. The long-term vision is not simply “AI for EEG” or “a better dashboard.” It is a system that can read brain activity, infer state changes, and eventually connect to the right form of intervention, whether that is electrical stimulation, magnetic stimulation, or a more precise optical approach.

That is why I care so much about modularity. A platform like g.tec already covers a large part of the sensing and real-time processing layer. Optogenetics represents a possible future actuation layer. NeuroLoop sits in the middle as the intelligence layer that turns raw physiology into action.

The challenge now is not whether the vision is interesting. The challenge is whether we can build the interface cleanly enough to make the system useful, testable, and scientifically honest. That means low latency, careful validation, and a realistic view of what current hardware can and cannot do.

The future of brain interfaces will not be defined by reading alone. It will be defined by systems that can read, decide, and respond. NeuroLoop is my attempt to build toward that future.